Mind the gap-missing device on the shelf? Retrospective experience with 5/7 Occlutech duct Occluder.
Acta Paediatr
; 113(4): 812-817, 2024 04.
Article
in En
| MEDLINE
| ID: mdl-38149770
ABSTRACT
AIM:
To describe our initial experience with the indications and results of the 5/7 Occlutech® duct Occluder (ODO, Occlutech International AB, Helsingborg, Sweden). A small incremental increase in occluder sizes is of utmost importance for successful outcomes, especially in smaller patients in whom protrusion of the distal disk towards the aorta should be minimised.METHODS:
Retrospective study of all patients undergoing PDA closure with the 5/7 ODO in three institutions since 2018.RESULTS:
The 5/7 ODO was used in 18 patients with median age and weight at the time of the procedure of 17.5 months (interquartile range 25th to 75th percentile 8 months- 4.4 years) and 13.6 kg (interquartile range 25th to 75th percentile 6.4-22.5 kg) respectively. All cases were successful. There were no cases of device embolisation, haemolysis, or flow disturbance of the LPA or the aorta.CONCLUSIONS:
This small retrospective study demonstrated an excellent outcome of transcatheter PDA closure with the 5/7 ODO. The device is a beneficial complement to the existing sizes of PDA devices, filling the gap between the 4/6 and 6/8 ODO and avoiding protrusion of a larger disk in the aortic isthmus.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ductus Arteriosus, Patent
/
Septal Occluder Device
Limits:
Child, preschool
/
Humans
Language:
En
Journal:
Acta Paediatr
Year:
2024
Document type:
Article
Affiliation country:
Sweden
Country of publication:
Norway